Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GSK plc (GSK) vs TKO Group Holdings Inc (TKO) Price & Performance

TKO Group Holdings IncTrade

Price performance (Past 24H)

Key statistics

GSK plc vs TKO Group Holdings Inc — how do they compare? GSK plc trades at $50.44 (market cap $102.60B), while TKO Group Holdings Inc trades at $195.31 (market cap $14.24B). The key difference: GSK plc is far larger — about 7.2× TKO Group Holdings Inc's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.

GSKTKO
Market Cap
$102.60B$14.24B
Sector
HealthTechnology
52-Week High
$61.18$224.96
52-Week Low
$38.22$176.49
Enterprise Value
$123.04B$18.60B
Dividend Yield
3.57%1.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GSK plc

GSK trades at $50.30, down 3.57% today, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $1.36 per share, beating estimates of $1.27, and announced a $2.52 billion cost-saving plan through 2029. Revenue growth remains steady at 5% constant currency, supported by vaccines and specialty medicines. Analyst consensus shows 31% buy ratings with 55% hold, indicating cautious optimism.

GSK's solid profitability and strategic cost initiatives support long-term growth, but near-term stock performance faces headwinds from bearish technicals and mixed analyst sentiment. Key risks include pipeline execution and regulatory challenges, while institutional ownership trends and recent FDA approvals provide stability. The current valuation at 16.02 P/E offers reasonable entry for patient investors.

TKO Group Holdings Inc

TKO trades at $195.15, up 3.03% today, with a bullish technical outlook supported by moving averages and strong institutional sentiment. The stock shows robust revenue growth, with Q2 2026 revenue reaching $1.55 billion (up 18% year-over-year, Business Wire, August 3, 2026), and raised full-year guidance. However, a high P/E ratio of 68.33 and mixed quarterly EPS results highlight valuation concerns amid solid operational performance.

The outlook remains positive due to strong media rights and live event momentum, but risks include earnings volatility and competitive pressures. Analyst consensus is strongly bullish with a $228.17 price target, suggesting ~17% upside potential from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK

About TKO Group Holdings Inc

TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.

Read more on TKO